Imexpharm Corporation
Sector: Manufacturing
Industry: Chemical - Pharmaceutical

Open
High
Low
Vol
Market Cap.
Remain Bid
Remain Ask
52Wk High
52Wk Low
52Wk Avg Vol
Foreign Buy
Frgn Owned(%)
Dividend
Dividend Yield
Beta
EPS
P/E
F P/E
BVPS
P/B
1 day | 5 days | 3 months | 6 months | 12 months
 
 
Overview
 
Profile
 
Trading Data
 
Technical Analysis
 
Financials
 
News & Events
 
Documents
 
Compare
 
History price
DatePriceChangeVolumeAvg. BuyAvg. SellForeign BuyForeign Sell
23/06/25 51,100 -500(-0.97%) 62,500676.75847.661,00010,300
20/06/25 51,600 +300(0.58%) 65,000886.33900.1811,4003,500
19/06/25 51,300 0(0.00%) 52,200671.5788.5390013,000
18/06/25 51,300 -300(-0.58%) 63,100657.49806.541003,900
17/06/25 51,600 0(0.00%) 66,900677.87757.7612,00013,400
Financials
Industry Peers
  News
IMP: Adjustment of foreign ownership limit
IMP: Approval of the selection of audit firm for the 2025 financial statements
IMP: Reporting dossiers on the change of the maximum foreign ownership ratio
IMP: Record date for 2024 cash dividend payment
IMP: Information of transferring shares of IMP from major shareholder
IMP: Approval of the 2024 cash dividend payment
IMP: Change in the content of Business Registration Certificate
  Download documents
   IMP: Regulations 2025
   IMP: Regulations 2025
   IMP: Resolution of Annual Shareholders' Meeting 2025 (Adjust)
   IMP: FS Quarter 1 of 2025
   IMP: 2025 Annual Shareholders’Meeting Documents
  Overview
Contact Listing Inf. Business Reg. Additional Inf. Events Notes
Exchange HoSE
Sector Manufacturing
Industry Chemical - Pharmaceutical
Listing date 12/04/2006
Chartered capital 1,540,427,620,000
Shares listed 154,042,762
Shares outstanding 154,008,962